Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
100 d » 100 μ (Expand Search), 100 _ (Expand Search), 100 g (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
100 d » 100 μ (Expand Search), 100 _ (Expand Search), 100 g (Expand Search)
-
19861
Effects of TTP2515 on metabolic and calorimetry parameters in leptin-deficient mice.
Published 2013“…(<b>C</b>) Body weight was significantly lower in TTP2515-treated mice on the 50 mg/kg dose. (<b>D</b>) Immediately upon starting the 50 mg/kg dose, mean respiratory quotient was significantly decreased in TTP2515 treated mice during the light cycle. …”
-
19862
-
19863
-
19864
-
19865
-
19866
-
19867
Screening TAS2R5 agonists for the receptor downregulation response to long- term agonist exposure.
Published 2025“…<p>HEK-293T cells stably expressing FLAG-tagged TAS2R5 were exposed in culture for 18 hrs to the indicated agonists at a concentration 10-fold greater than their functional EC<sub>50</sub> values. …”
-
19868
Contribution of anti-MPER antibodies to the plasma's cross-neutralizing activities.
Published 2011“…</p>d<p>The neutralizing activities of plasmas collected at the indicated time points following infection were evaluated against the HIV-1 viruses JRFL and TRO.11 in the absence or presence of the MPER peptide (NEQELL<u>ELDKWASLWNWFDITN</u>WLWYIRKKK). The Log10 decrease in IC50 neutralization titers in the presence of the MPER peptide is indicated.…”
-
19869
-
19870
-
19871
Cytotoxicity profiles of multi-walled carbon nanotubes with different physico-chemical properties
Published 2020“…Rigid, needle-shaped MWCNTs with a large diameter (>50 µm) penetrated the cytoplasm and decreased cell survival without generating intracellular reactive oxygen species (ROS), significantly up-regulated many genes involved in inflammatory responses, response to oxidative stress and apoptosis, and extracellular matrix degradation. …”
-
19872
Time Since Deposition Signatures for the Analysis of Canine Body Fluid
Published 2025“…<p dir="ltr">Although dogfighting is a felony in all 50 states, it has grown into a substantial enterprise that is often tied to other organized crime activities including gambling, narcotics, and weapons trafficking. …”
-
19873
Efficacy of sertraline against Trypanosoma cruzi: an in vitro and in silico study
Published 2018“…Considering the mammalian cytotoxicity, the drug resulted in a selectivity index of 17.8. Sertraline induced a change in the mitochondrial integrity of T. cruzi, resulting in a decrease in ATP levels, but not affecting reactive oxygen levels or plasma membrane permeability. …”
-
19874
-
19875
-
19876
Exploring <i>in vitro</i> anticancer potential of <i>Ferula gummosa</i> gum on PC-3 cells: insights from cellular and molecular studies
Published 2025“…Alongside this, we observed a decrease in intracellular ROS levels and a weakening of the mitochondrial membrane potential. …”
-
19877
Rac1 inhibition specifically affects the dynamics of paxillin in adhesions.
Published 2012“…<p>(A) Images of FRAP time series of GFP-paxillin-expressing NIH 3T3 cells ±50 μM Rac1 inhibitor. …”
-
19878
Determinants of study power.
Published 2013“…<p><b>A</b>. Study power decreases with increasing sample storage time (▪0 years, ▴ 5 years, •10 years). …”
-
19879
PKA activation prevents GABA<sub>B</sub> modulation of SK.
Published 2016“…(F) Summary data for panels A-B. (G) Summary data for panels C-D. (H) Top, inhibiting PKA with 10 μM H89 significantly decreases SK current (n = 6, Wilcoxon signed rank test, p = 0.0313). …”
-
19880
Modeling of <i>In-Utero</i> and <i>Intra-Partum</i> Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV
Published 2015“…</p><p>Trial Registration</p><p>This analysis is based on secondary data obtained from three clinical trials. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT00386230" target="_blank">NCT00386230</a>, <a href="https://clinicaltrials.gov/ct2/show/NCT00398684" target="_blank">NCT00398684</a>, <a href="https://clinicaltrials.gov/ct2/show/NCT00409591" target="_blank">NCT00409591</a>.…”